Annemie Narkus

Double‐blind, placebo‐controlled, dose‐ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber

Wally Meyer, Annemie Narkus, A. Salapatek et al. · Allergy · 2013 · 70 citations

Prospective validation of ‘Allergy-Control-SCORETM’: a novel symptom-medication score for clinical trials

D. Häfner, Kristian Reich, Paolo Maria Matricardi et al. · Allergy · 2011 · 55 citations

The placebo effect in allergen‐specific immunotherapy trials

Annemie Narkus, Ulrike Lehnigk, Dietrich Haefner et al. · Clinical and Translational Allergy · 2013 · 54 citations · Full text

Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1‐FV in a randomized controlled trial

Ludger Klimek, Claus Bachert, Karl‐Friedrich Lukat et al. · Clinical and Translational Allergy · 2015 · 53 citations · Full text

Clinical effects of specific immunotherapy: a two-year double-blind, placebo-controlled study with a one year follow-up.

D. Dokic, J Schnitker, Annemie Narkus et al. · PubMed · 2005 · 24 citations